600 patients66,869 observations120 daysLIVE

Patient P-01598

Synthetic patientNBL-101 · Day 109 · 25–34 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Unstable
Inflammatory state
Stable
Nutritional resilience
Unstable
Discontinuation risk
75%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 47 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 58 GI-04 recommendedGI Support Protocol GI-04
  4. Day 59 Patient acceptedStarted GI-04 in the companion
  5. Day 67 No meaningful changeGI Support Protocol GI-04
  6. Day 69 ME-01 recommendedMonitoring Escalation ME-01
  7. Day 70 Patient acceptedStarted ME-01 in the companion
  8. Day 73 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 47.

Primary contributors, last 14 days
  • Nutritional resilience-7
  • Treatment adherence+7
  • GI instability+3
  • Toxicity-2

What helped?

  • GI Support Protocol GI-04Day 58
    Result: no meaningful change
  • Monitoring Escalation ME-01Day 69
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
Dietary Support Protocol NP-02
58%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
60.6/100
stable · -0.3 vs previous 14 d
Toxicity
Blood
48.7/100
stable · -1.0 vs previous 14 d
Sleep quality
Wearable
23/100
improving · +3.1 vs previous 14 d
Energy level
Daily log
2.1/10
improving · +0.1 vs previous 14 d
Stress level
Daily log
6.5/10
stable · -0.2 vs previous 14 d
Steps
Wearable
7,764
stable · +96 vs previous 14 d
Adherence
Companion
51.4 %
improving · +2.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 27 from the failing basin, 63 from restoration.

Would help
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 70%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 70%
  • CR-01 Clinician Review
    100% improved among 8 similar · onset 5 d · confidence 70%
Would not help
  • GI-04 GI Support Protocol
    already tried, no meaningful change
  • Keep fat low
    GI +3.1 next day on high-intake days · n 17
  • Keep simple carbs low
    GI +2.3 next day on high-intake days · n 19
  • Keep fibre low
    GI +1.9 next day on high-intake days · n 19
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +3.1detractor · 95%
  • Simple carbohydrates
    +2.3detractor · 89%
  • Insoluble fibre
    +1.9detractor · 73%
  • Alcohol
    +1.9detractor · 75%
  • Histamine load
    +0.2no signal · 15%
  • Spicy / capsaicin
    +0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Drug metabolism and exposure 60
    • DNACYP2D6 poor metabolizer → higher exposure
    • BloodToxicity index 49
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 38/100
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 45
    • WearableResting HR 72 bpm
    • WearableShort sleep window
  • Mucosal barrier integrity 30
    • Daily logGI symptom score 61 and rising
    • WearableSleep 5.4 h, below personal baseline
  • Inflammatory signalling 25
    • BloodInflammatory load index 55
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 2 · butyrate capacity 38/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
55 ms
Sleep
5.4 h
Steps
7,088
Resting HR
68 bpm
Daily log: GI score 61, nutritional resilience 35, adherence 51.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0132857%S14SC-12no change49
P-0167557%S14NP-02improved38
P-0138954%S14SC-12improved46
P-0149454%S14GI-04improved42
P-0183454%S14NP-02improved44
P-0141353%S14GI-04improved44
P-0184553%S14NP-02improved47
P-0189153%S14SC-12improved41
P-0153152%S14ME-01improved51
P-0141250%S14NP-02improved49
P-0143350%S14GI-04improved48
P-0143650%S14GI-04improved38